These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 22101450

  • 21. [Pimobendan (UDCG 115 BS) in long-term therapy of chronic heart failure].
    Bergler-Klein J, Globits S, Stefenelli T, Mayr H, Porenta G, Sochor H, Glogar D.
    Z Kardiol; 1992 Oct; 81(10):546-52. PubMed ID: 1441695
    [Abstract] [Full Text] [Related]

  • 22. Effect of oral administration of pimobendan in cats with heart failure.
    Gordon SG, Saunders AB, Roland RM, Winter RL, Drourr L, Achen SE, Hariu CD, Fries RC, Boggess MM, Miller MW.
    J Am Vet Med Assoc; 2012 Jul 01; 241(1):89-94. PubMed ID: 22720992
    [Abstract] [Full Text] [Related]

  • 23. Treatment of congestive heart failure in dogs.
    Boswood A, Dukes-McEwan J, French A, Little C, Patteson M, Swift S, Smith S, Willis R.
    Vet Rec; 2008 Oct 25; 163(17):520. PubMed ID: 18953081
    [No Abstract] [Full Text] [Related]

  • 24. Evaluation of a fixed-dose combination of benazepril and pimobendan in dogs with congestive heart failure: a randomized non-inferiority clinical trial.
    King JN, Hirakawa A, Sonobe J, Otaki H, Sakakibara N, Seewald W, Forster S.
    J Vet Sci; 2018 Jan 31; 19(1):117-128. PubMed ID: 28693297
    [Abstract] [Full Text] [Related]

  • 25. Lack of efficacy of low-dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs.
    Schuller S, Van Israël N, Vanbelle S, Clercx C, McEntee K.
    J Vet Pharmacol Ther; 2011 Aug 31; 34(4):322-31. PubMed ID: 20950346
    [Abstract] [Full Text] [Related]

  • 26. A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure.
    Katz SD, Kubo SH, Jessup M, Brozena S, Troha JM, Wahl J, Cohn JN, Sonnenblick EH, LeJemtel TH.
    Am Heart J; 1992 Jan 31; 123(1):95-103. PubMed ID: 1729854
    [Abstract] [Full Text] [Related]

  • 27. Effects of pimobendan in cats with hypertrophic cardiomyopathy and recent congestive heart failure: Results of a prospective, double-blind, randomized, nonpivotal, exploratory field study.
    Schober KE, Rush JE, Luis Fuentes V, Glaus T, Summerfield NJ, Wright K, Lehmkuhl L, Wess G, Sayer MP, Loureiro J, MacGregor J, Mohren N.
    J Vet Intern Med; 2021 Mar 31; 35(2):789-800. PubMed ID: 33543810
    [Abstract] [Full Text] [Related]

  • 28. A promising new inotrope: levosimendan.
    Fotbolcu H, Duman D.
    Anadolu Kardiyol Derg; 2010 Apr 31; 10(2):176-82. PubMed ID: 20382619
    [Abstract] [Full Text] [Related]

  • 29. Effect of prespecified therapy escalation on plasma NT-proBNP concentrations in dogs with stable congestive heart failure due to myxomatous mitral valve disease.
    Hezzell MJ, Block CL, Laughlin DS, Oyama MA.
    J Vet Intern Med; 2018 Sep 31; 32(5):1509-1516. PubMed ID: 30216549
    [Abstract] [Full Text] [Related]

  • 30. Long-term Outcome of Irish Wolfhound Dogs with Preclinical Cardiomyopathy, Atrial Fibrillation, or Both Treated with Pimobendan, Benazepril Hydrochloride, or Methyldigoxin Monotherapy.
    Vollmar AC, Fox PR.
    J Vet Intern Med; 2016 Sep 31; 30(2):553-9. PubMed ID: 26936799
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of pimobendan in dogs with cardiomegaly caused by preclinical mitral valve disease.
    Boswood A, Smith S, Patteson M.
    Vet Rec; 2011 Feb 26; 168(8):222. PubMed ID: 21493561
    [No Abstract] [Full Text] [Related]

  • 32. The cardiac effects of pimobendan (but not amrinone) are preserved at rest and during exercise in conscious dogs with pacing-induced heart failure.
    Ohte N, Cheng CP, Suzuki M, Little WC.
    J Pharmacol Exp Ther; 1997 Jul 26; 282(1):23-31. PubMed ID: 9223536
    [Abstract] [Full Text] [Related]

  • 33. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C, Tousoulis D, Koumallos N, Marinou K, Stefanadis C.
    Pharmacol Ther; 2007 May 26; 114(2):184-97. PubMed ID: 17363065
    [Abstract] [Full Text] [Related]

  • 34. [Acute and long-term effects of pimobendan (UD-CG 115) in NYHA II and III heart failure. Results of a randomized multicenter double-blind study].
    Assmann I, Kassel P, Duck HG, Fiehring H, Morgan P, Schmidt PK, Höfs T, Nehmiz G.
    Z Kardiol; 1991 Nov 26; 80(11):687-94. PubMed ID: 1792811
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of pimobendan and N-terminal probrain natriuretic peptide in the treatment of pulmonary hypertension secondary to degenerative mitral valve disease in dogs.
    Atkinson KJ, Fine DM, Thombs LA, Gorelick JJ, Durham HE.
    J Vet Intern Med; 2009 Nov 26; 23(6):1190-6. PubMed ID: 19780931
    [Abstract] [Full Text] [Related]

  • 36. Diagnosis and treatment of congestive heart failure secondary to dilated cardiomyopathy in a hedgehog.
    Delk KW, Eshar D, Garcia E, Harkin K.
    J Small Anim Pract; 2014 Mar 26; 55(3):174-7. PubMed ID: 24372164
    [Abstract] [Full Text] [Related]

  • 37. A double-blind, randomized, placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy.
    Fuentes VL, Corcoran B, French A, Schober KE, Kleemann R, Justus C.
    J Vet Intern Med; 2002 Mar 26; 16(3):255-61. PubMed ID: 12041654
    [Abstract] [Full Text] [Related]

  • 38. Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases.
    de Madron E, King JN, Strehlau G, White RV.
    Can Vet J; 2011 Nov 26; 52(11):1219-25. PubMed ID: 22547843
    [Abstract] [Full Text] [Related]

  • 39. Pharmacotherapy of congestive heart failure: pimobendan, a new approach to inotropic stimulation. Proceedings of a satellite symposium to the Xth European Congress of Cardiology. Vienna, Austria, August 31, 1988.
    J Cardiovasc Pharmacol; 1989 Nov 26; 14 Suppl 2():S1-64. PubMed ID: 2478785
    [No Abstract] [Full Text] [Related]

  • 40. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group.
    Ettinger SJ, Benitz AM, Ericsson GF, Cifelli S, Jernigan AD, Longhofer SL, Trimboli W, Hanson PD.
    J Am Vet Med Assoc; 1998 Dec 01; 213(11):1573-7. PubMed ID: 9838955
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.